Wednesday, April 22, 2026

Global Trust: K9 Howitzer’s 10-Nation Success Proves US Ally Is the New Defense Backbone

SNT Group showcases advanced defense technologies at ADEX 2025, featuring innovations in small arms and vehicle systems for global clients.

The Princess Without a Title: Kim Ju-ae Trails in North Korea’s Succession Race

Former lawmaker Tae Yong-ho explains Kim Ju-ae's successor training, noting she hasn't been officially designated as heir yet.

UN Human Rights Council’s New Resolution: What It Means for North Korean Human Rights in 2026

The NHRCK supports the UN resolution on North Korean human rights, urging global action and highlighting ongoing concerns over abuses.

Dae Hyeon Moon

SelvasAI, Mediana, and ezCaretech to Develop AI-Powered Smart Ward Solutions

Selvas AI, Mediana, and ezCaretech partner to create an AI-driven smart ward solution, enhancing healthcare efficiency and patient safety.

Emocog’s Cogthera is Revolutionizing MCI Treatment in 2026

Emocog develops innovative digital therapeutics for mild cognitive impairment, enhancing dementia care through early intervention and AI technology.

Daewoong Pharmaceutical’s AI-Driven Solutions for Vulnerable Communities

Daewoong Pharmaceutical's CEO discusses innovative digital healthcare solutions to enhance access and monitoring for vulnerable populations.

Transforming Healthcare: How Daewoong Pharmaceutical’s Digital Health Strategy Aims for 1 Trillion KRW in 5 Years

Daewoong Pharmaceutical's CEO Lee Chang-jae discusses shifting focus to predictive healthcare and aims for 1 trillion KRW in digital healthcare revenue.

2026 MedTech Spotlight: How Korea’s Medical Device Industry is Shaping Global Partnerships

South Korea's MedTech Spotlight event fosters global collaboration, emphasizing proactive partnerships and market strategies for medical devices.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

AI Kidney: Revolutionizing Kidney Disease Prediction with U.S. Market Launch

Rokit Healthcare has completed certification for its AI kidney disease prediction solution, 'AI Kidney,' for the U.S. market.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Daewoong’s Hub System Aims to End Drug Shortages With Predictive Data

Daewoong Pharmaceutical is enhancing drug distribution with a data-driven hub system for better inventory management and transparency.

Lunit Scope: How AI Biomarkers Are Revolutionizing Cancer Treatment at AACR 2026

Lunit to present six AI biomarker studies at AACR 2026, showcasing advancements in cancer treatment and AI technology.

How Dongkoo Bio & Pharma Plans to Conquer Southeast Asia’s Aesthetic Market with DERMAROSA

Dongkoo Bio & Pharma partners with Areum Medics and Adization Inc. to expand its global aesthetic market presence with Dermarosa.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

How Korea’s New Digital Health Device Certification Will Impact Your Wellness Tech in 2026

The Korea AI Healthcare Research Institute gains certification authority for digital health devices, enhancing testing and industry support.

Top News

- Our Sponsors Ad -

Follow us